Main > PEDIATRICS > Pneumology > Respiratory Distress Syndrome > Treatment > Surfactants. > PorActant Alfa > NonGeneric PorActant Alfa > Patent. > Claims > Claim 1: Animal Lung Surfactant: > a) Polar PhosphoLipids (98.5-99%); > PhosphatidylCholine (>70-75%) > DiPalmitoylPhosphatidylCholine > (40-45%) & b) Hydrophobic Low MW

---

(40-45%) & b) Hydrophobic Low MW's subsections
(3-14 KD) Proteins (<1.5%). Claim

(40-45%) & b) Hydrophobic Low MW's products
This section has no products